Drug
ASM-024 clinical trials
Also written ASM-024.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Development codes
- ASM-024
- 4
Studies by the year they started
4 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Asmacure Ltée (4)
Studies
Open first, then newest update. How each study uses ASM-024 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate AsthmaTerminatedPhase 1/2Asmacure LtéeNCT01793298Written as ASM-024
- Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Asmacure LtéeNCT01855230Written as ASM-024
- Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate AsthmaCompletedPhase 2Asmacure LtéeNCT01190826Written as ASM-024
- Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic AsthmaCompletedPhase 2Asmacure LtéeNCT01092403Written as ASM-024
Codes
What other systems call ASM-024 · ClinicalTrials.gg INT000360
- Wikidata Q27287845asm-024One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27287845 | asm-024 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.